PREDICTION MODEL FOR CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION AND TYPE 2 DIABETES MELLITUS

被引：0
|
作者：
Medentseva, O. [1 ]
Udovychenko, M. [1 ]
Rudyk, I. [1 ]
Gasanov, I. [1 ]
Ovrakh, T. [2 ]
Galchinskaya, V. [3 ]
Pyvovar, S. [1 ]
机构：
[1] SI Natl Inst Therapy, Dept Clin Pharmacol, Kharkov, Ukraine
[2] SI Natl Inst Therapy, Dept Atherosclerosis, Kharkov, Ukraine
[3] SI Natl Inst Therapy, Lab Immunobiochem & Mol Genet, Kharkov, Ukraine
来源：
JOURNAL OF HYPERTENSION | 2019年 / 37卷
关键词：
D O I：
10.1097/01.hjh.0000571836.74475.02
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E142 / E142
页数：1
相关论文
共 50 条
  • [1] METABOLIC BIOMARKERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Sveklina, Tatiana S.
    Shustov, Sergey B.
    Kolyubayeva, Svetlana N.
    Kuchmin, Alexey N.
    Kozlov, Vadim A.
    Smirnova, Elena V.
    Zharkov, Alexandr V.
    DIABETES MELLITUS, 2024, 27 (01): : 15 - 24
  • [2] IRISIN PREDICTED HEART FAILURE WITH PRESERVED EJECTION FRACTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Berezin, A.
    Fushtey, I.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A151 - A151
  • [3] UTILIZATION OF BOTH IRISIN AND APELIN IN PREDICTION OF HEART FAILURE WITH PRESERVED EJECTION FRACTION IN TYPE 2 DIABETES MELLITUS PATIENTS
    Berezin, A. A.
    Fushtey, I. M.
    ATHEROSCLEROSIS, 2022, 355 : E286 - E286
  • [4] History of diabetes mellitus type 2 and prognosis in acute heart failure with preserved ejection fraction
    Bohlen Delgado, A. P.
    Moreira, D.
    Rodrigues, B.
    Marmelo, B.
    Correia, E.
    Nunes, S.
    Gama, P.
    Santos, O.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S183 - S183
  • [5] DIASTOLIC DYSFUNCTION AND HEART FAILURE WITH PRESERVED EJECTION FRACTION IN PATIENTS WITH RESISTANT HYPERTENSION AND TYPE 2 DIABETES MELLITUS
    Manukyan, M. A.
    Falkovskaya, A. Yu
    Zyubanova, I., V
    Lichikaki, V. A.
    Tsoi, E., I
    Ryabova, T. R.
    Gusakova, A. M.
    Suslova, T. E.
    Mordovin, V. F.
    KARDIOLOGIYA, 2022, 62 (08) : 11 - 18
  • [6] PREDICTORS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TREATED WITH EMPAGLIFLOZIN
    Lebedev, Denis
    Lyasnikova, Elena
    Vasilyeva, Elena
    Sitnikova, Maria
    Babenko, Alina
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL 1) : E190 - E190
  • [7] PREDICTORS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TREATED WITH EMPAGLIFLOZIN
    Lebedev, Denis
    Lyasnikova, Elena
    Vasilyeva, Elena
    Sitnikova, Maria
    Babenko, Alina
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E190 - E190
  • [8] Effect of Luseogliflozin on Heart Failure With Preserved Ejection Fraction in Patients With Diabetes Mellitus
    Ejiri, Kentaro
    Miyoshi, Toru
    Kihara, Hajime
    Hata, Yoshiki
    Nagano, Toshihiko
    Takaishi, Atsushi
    Toda, Hironobu
    Nanba, Seiji
    Nakamura, Yoichi
    Akagi, Satoshi
    Sakuragi, Satoru
    Minagawa, Taro
    Kawai, Yusuke
    Nishii, Nobuhiro
    Fuke, Soichiro
    Yoshikawa, Masaki
    Nakamura, Kazufumi
    Ito, Hiroshi
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (16):
  • [9] Molecular and pathophysiological links between heart failure with preserved ejection fraction and type 2 diabetes mellitus
    Papp, Zoltan
    Radovits, Tamas
    Paulus, Walter J.
    Hamdani, Nazha
    Seferovic, Petar M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (12) : 1649 - 1652
  • [10] Heart failure with preserved ejection fraction (HFpEF) in type 2 diabetes mellitus: from pathophysiology to therapeutics
    Abudureyimu, Miyesaier
    Luo, Xuanming
    Wang, Xiang
    Sowers, James R.
    Wang, Wenshuo
    Ge, Junbo
    Ren, Jun
    Zhang, Yingmei
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2022, 14 (05)
12345